###begin article-title 0
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 86 89 86 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 40 44 <span type="species:ncbi:10090">Mice</span>
Induction of Ovarian Leiomyosarcomas in Mice by Conditional Inactivation of Brca1 and p53
###end article-title 0
###begin p 1
Conceived and designed the experiments: DC. Performed the experiments: BAQ TB XH KBJ DC. Analyzed the data: BAQ TB SL LHE DC. Wrote the paper: DC.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 191 196 191 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 226 231 226 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 249 252 249 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 276 284 <span type="species:ncbi:9606">patients</span>
Approximately one out of every ten cases of epithelial ovarian cancer (EOC) is inherited. The majority of inherited cases of EOC result from mutations in the breast cancer associated gene 1 (BRCA1). In addition to mutation of BRCA1, mutation of the p53 gene is often found in patients with inherited breast and ovarian cancer syndrome.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 58 61 58 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 151 156 151 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 164 167 164 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 269 278 269 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 264 278 264 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup></italic>
###xml 286 295 286 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 283 295 283 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>LoxP/LoxP</sup></italic>
###xml 519 528 517 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 514 528 512 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup></italic>
###xml 536 545 534 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 533 545 531 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>LoxP/LoxP</sup></italic>
###xml 812 821 810 819 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 807 821 805 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup></italic>
###xml 829 838 827 836 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 826 838 824 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>LoxP/LoxP</sup></italic>
###xml 935 944 933 942 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 932 944 930 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>LoxP/LoxP</sup></italic>
###xml 98 103 <span type="species:ncbi:10090">mouse</span>
###xml 364 368 <span type="species:ncbi:10090">mice</span>
###xml 468 472 <span type="species:ncbi:10090">mice</span>
###xml 478 482 <span type="species:ncbi:10090">mice</span>
We investigated the role of loss of function of BRCA1 and p53 in ovarian cancer development using mouse models with conditionally expressed alleles of Brca1 and/or p53. Our results show that ovary-specific Cre-recombinase-mediated conditional inactivation of both Brca1LoxP/LoxP and p53LoxP/LoxP resulted in ovarian or reproductive tract tumor formation in 54% of mice, whereas conditional inactivation of either allele alone infrequently resulted in tumors (</=5% of mice). In mice with conditionally inactivated Brca1LoxP/LoxP and p53LoxP/LoxP, ovarian tumors arose after long latency with the majority exhibiting histological features consistent with high grade leiomyosarcomas lacking expression of epithelial, follicular or lymphocyte markers. In addition, tumors with conditional inactivation of both Brca1LoxP/LoxP and p53LoxP/LoxP exhibited greater genomic instability compared to an ovarian tumor with inactivation of only p53LoxP/LoxP.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 52 55 52 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 263 268 263 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 273 276 273 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 330 336 330 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1-</italic>
###xml 315 320 <span type="species:ncbi:10090">mouse</span>
Although conditional inactivation of both Brca1 and p53 results in ovarian tumorigenesis, our results suggest that additional genetic alterations or alternative methods for targeting epithelial cells of the ovary or fallopian tube for conditional inactivation of Brca1 and p53 are required for the development of a mouse model of Brca1-associated inherited EOC.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 255 260 255 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 264 269 264 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
###xml 285 288 285 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Lynch1">[1]</xref>
###xml 290 293 290 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Pal1">[2]</xref>
###xml 295 298 295 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Risch1">[3]</xref>
###xml 301 306 301 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 311 316 311 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
###xml 628 631 628 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Narod1">[4]</xref>
###xml 633 636 633 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Venkitaraman1">[5]</xref>
###xml 653 658 653 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 752 755 740 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Lynch1">[1]</xref>
###xml 757 760 745 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Pal1">[2]</xref>
###xml 762 765 750 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Risch1">[3]</xref>
###xml 793 798 781 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 1094 1097 1082 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Rathi1">[6]</xref>
###xml 1099 1102 1087 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Hilton1">[7]</xref>
###xml 1104 1107 1092 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Geisler1">[8]</xref>
###xml 1109 1112 1097 1100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Chan1">[9]</xref>
###xml 1114 1118 1102 1106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Signori1">[10]</xref>
###xml 1150 1155 1138 1143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 1160 1165 1148 1153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
###xml 1183 1186 1171 1174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1275 1279 1263 1267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Buller1">[11]</xref>
###xml 1281 1285 1269 1273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Ramus1">[12]</xref>
###xml 1287 1291 1275 1279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Rhei1">[13]</xref>
###xml 1293 1297 1281 1285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Schorge1">[14]</xref>
###xml 1314 1317 1302 1305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1362 1367 1350 1355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 1480 1484 1468 1472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Buller1">[11]</xref>
###xml 1486 1490 1474 1478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Ramus1">[12]</xref>
###xml 1492 1496 1480 1484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Rhei1">[13]</xref>
###xml 1498 1502 1486 1490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Schorge1">[14]</xref>
###xml 1515 1518 1503 1506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1522 1527 1510 1515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 1618 1621 1606 1609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1627 1632 1615 1620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 1726 1730 1714 1718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Brodie1">[15]</xref>
###xml 1732 1736 1720 1724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Liu1">[16]</xref>
###xml 1217 1225 <span type="species:ncbi:9606">patients</span>
###xml 1707 1712 <span type="species:ncbi:10090">mouse</span>
###xml 1714 1717 <span type="species:ncbi:10090">GEM</span>
Approximately 10% of cases of epithelial ovarian cancer (EOC) are associated with a clear hereditary predisposition to disease; the vast majority of cases resulting from inherited alterations in the breast cancer-associated tumor suppressor genes 1 or 2 (BRCA1 or BRCA2) (reviewed in: [1], [2], [3]). BRCA1 and BRCA2 were originally identified based on genetic linkage to families with an increased risk of breast and ovarian cancer. The proteins encoded by these genes control normal cellular growth by their involvement in DNA damage repair, maintenance of genomic integrity, chromatin remodeling and transcription regulation [4], [5]. Linkage to the BRCA1 gene exists in approximately80% of families with inherited risk of breast and ovarian cancer [1], [2], [3]. Although mutations of the BRCA1 gene are not frequently detected in sporadic cases of EOC, recent studies have suggested that other mechanisms of inactivation of this tumor suppressor gene, such as promoter methylation and mutations in non-coding regions that effect functional protein expression, may exist in sporadic tumors [6], [7], [8], [9], [10]. In addition to alterations in BRCA1 and BRCA2, mutation of the p53 gene is reported in 70-90% of patients with familial breast and ovarian cancer syndrome [11], [12], [13], [14]. Interestingly, p53 mutations are identified more frequently in BRCA1-associated and sporadic serous ovarian carcinomas than in sporadic ovarian cancers of other histologic subtypes [11], [12], [13], [14]. A role for p53 in BRCA1-associated inherited breast and ovarian cancer is further supported by the cooperation of p53 with BRCA1 in the development of mammary tumor development in genetically engineered mouse (GEM) models [15], [16].
###end p 9
###begin p 10
###xml 64 68 64 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Connolly1">[17]</xref>
###xml 70 74 70 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Dinulescu1">[18]</xref>
###xml 76 80 76 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-FleskenNikitin1">[19]</xref>
###xml 82 86 82 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Orsulic1">[20]</xref>
###xml 88 92 88 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Wu1">[21]</xref>
###xml 130 135 130 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 171 175 171 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Brodie1">[15]</xref>
###xml 177 181 177 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Liu1">[16]</xref>
###xml 219 224 219 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 409 414 409 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 570 575 570 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 718 723 718 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 746 750 746 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Chodankar1">[22]</xref>
###xml 752 756 752 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-ClarkKnowles1">[23]</xref>
###xml 828 833 828 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 922 927 922 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 927 931 927 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Liu1">[16]</xref>
###xml 933 937 933 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Xu1">[24]</xref>
###xml 1029 1033 1029 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Chodankar1">[22]</xref>
###xml 1084 1099 1084 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre-recombinase</italic>
###xml 1099 1103 1099 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-ClarkKnowles1">[23]</xref>
###xml 1163 1168 1163 1168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 1210 1214 1210 1214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-ClarkKnowles1">[23]</xref>
###xml 1225 1229 1225 1229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Chodankar1">[22]</xref>
###xml 1350 1357 1350 1357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 1436 1441 1436 1441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 1446 1449 1446 1449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1512 1517 1512 1517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 1522 1525 1522 1525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1560 1563 1560 1563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myc</italic>
###xml 1659 1663 1659 1663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Xing1">[25]</xref>
###xml 1782 1787 1782 1787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 1792 1795 1792 1795 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1830 1837 1830 1837 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 1897 1902 1897 1902 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 2034 2039 2034 2039 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 2039 2043 2039 2043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Liu1">[16]</xref>
###xml 2092 2095 2092 2095 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 2095 2099 2095 2099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Jonkers1">[26]</xref>
###xml 2148 2151 2148 2151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 2151 2155 2151 2155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Lang1">[27]</xref>
###xml 2243 2247 2243 2247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Dittmer1">[28]</xref>
###xml 2249 2253 2249 2253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Hollstein1">[29]</xref>
###xml 2255 2259 2255 2259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Olivier1">[30]</xref>
###xml 46 49 <span type="species:ncbi:10090">GEM</span>
###xml 114 119 <span type="species:ncbi:10090">mouse</span>
###xml 193 198 <span type="species:ncbi:10090">mouse</span>
###xml 614 618 <span type="species:ncbi:10090">mice</span>
###xml 680 684 <span type="species:ncbi:10090">mice</span>
###xml 883 887 <span type="species:ncbi:10090">mice</span>
###xml 1654 1658 <span type="species:ncbi:10090">mice</span>
###xml 1882 1887 <span type="species:ncbi:10090">mouse</span>
###xml 2006 2010 <span type="species:ncbi:10090">mice</span>
###xml 2064 2068 <span type="species:ncbi:10090">mice</span>
###xml 2229 2234 <span type="species:ncbi:9606">human</span>
Despite recent advances in the development of GEM models of EOC [17], [18], [19], [20], [21] and the existence of mouse models of Brca1-associated inherited breast cancer [15], [16], analogous mouse models that develop Brca1-associated inherited invasive EOC have been more difficult to develop. The delay in developing such a model owes largely to controversy over the identity of the cell type of origin of BRCA1-associated inherited invasive EOC and the resultant difficulty in targeting molecular alterations to the correct cell type. Because homozygous deletion of Brca1 leads to early embryonic lethality in mice, attempts to establish such a model have employed strains of mice with conditional inactivation of Brca1. Two previous studies [22], [23] investigated the effects of ovary-specific conditional inactivation of Brca1 using distinct genetically engineered strains of mice harboring LoxP-flanked alleles of Brca1[16], [24]. In these studies, ovary-specific Cre-recombinase expression was achieved by genetic means [22] or by direct administration of adenovirus encoded Cre-recombinase[23]. In both cases, ovary-specific conditional inactivation of Brca1 led to the development of pre-neoplastic [23] or benign [22] epithelial lesions in the ovary, but in neither case were invasive ovarian cancers observed. A separate study, using an ex vivo retroviral transduction strategy for conditional inactivation of LoxP-flanked Brca1 and p53 alleles in ovarian explants, showed that inactivation of both Brca1 and p53 in conjunction with expression of Myc led to transformation of ovarian cells and that these cells were tumorigenic in recipient mice [25]. In the present study, we sought to extend these previous observations by testing whether conditional inactivation of Brca1 and p53 in the ovarian surface epithelium in situ is sufficient to establish an autochthonous mouse model of BRCA1-associated invasive EOC. To this end, we used previously established strains of genetically engineered mice harboring LoxP-flanked Brca1[16] in conjunction with mice harboring LoxP-flanked p53[26] or a missense gain-of-function mutant allele of p53[27] that is analogous to the R175H hotspot mutation frequently identified in human cancers [28], [29], [30].
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
Intrabursal Administration of Adenovirus Results in Efficient Infection of Ovarian Surface Epithelial Cells
###end title 12
###begin p 13
###xml 8 13 8 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 13 16 13 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 58 61 58 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 61 64 61 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 226 230 226 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP</italic>
###xml 262 267 262 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 272 275 272 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 372 376 372 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Sauer1">[31]</xref>
###xml 917 921 917 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Dinulescu1">[18]</xref>
###xml 923 927 923 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-FleskenNikitin1">[19]</xref>
###xml 929 933 929 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Wu1">[21]</xref>
###xml 935 939 935 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-ClarkKnowles1">[23]</xref>
###xml 1073 1074 1073 1074 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 1487 1496 1481 1490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008404-g001">Figure 1A</xref>
###xml 28 32 <span type="species:ncbi:10090">mice</span>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
###xml 199 204 <span type="species:ncbi:10090">mouse</span>
###xml 406 411 <span type="species:ncbi:10090">mouse</span>
###xml 838 842 <span type="species:ncbi:10090">mice</span>
###xml 882 885 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1027 1031 <span type="species:ncbi:10090">mice</span>
###xml 1089 1092 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1268 1271 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Because Brca1-/- (knockout) mice are embryonic lethal and p53-/- mice develop and succumb from tumors (e.g., lymphoma, sarcoma, etc.) at young ages, the present study utilized genetically engineered mouse strains that express LoxP recombination sites within the Brca1 and p53 alleles, thus allowing conditional inactivation of each allele upon exposure to Cre-recombinase [31]. Since there are no existing mouse models that exhibit ovarian surface epithelium (OSE)-restricted expression of Cre-recombinase, we chose a viral approach for conditional Cre-mediated inactivation of LoxP-flanked alleles by intrabursal administration of Adenovirus-Cre. To demonstrate our capability to successfully perform intrabursal injections that result in OSE-restricted viral infection, we performed pilot experiments in which 8 week-old female C57Bl/6 mice received intrabursal injections of Ad5-CMV-ntLacZ as previously described [18], [19], [21], [23]. To test the extent and localization of viral infection, eight week-old female C57Bl/6 mice were given intrabursal injections of 5x107 p.f.u. of Ad5-CMV-ntLacZ and euthanized one week post-surgery. Ovaries were dissected, snap frozen, sectioned and stained for beta-galactosidase expression. Single intrabursal injection of Ad5-CMV-ntLacZ resulted in high efficiency, tissue restricted infection of the OSE with little or no infection of the underlying ovarian stromal tissue as shown by the beta-galactosidase staining of thin sections of ovary (Figure 1A, panels a and b). Although staining was predominantly confined to the OSE, occasional beta-galactosidase positive cells were observed in the fallopian tube (1A, panel c). No evidence of beta-galactosidase staining was detected in the uterus or other organs indicating that viral infection had not spread beyond the site of injection (data not shown).
###end p 13
###begin title 14
Intrabursal injection of Adenovirus results in ovarian surface epithelial cell-restricted infection.
###end title 14
###begin p 15
###xml 588 593 578 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 602 611 592 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 597 611 587 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup></italic>
###xml 618 623 608 613 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt/wt</sup>
###xml 613 623 603 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>wt/wt</sup></italic>
###xml 630 632 620 622 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 625 632 615 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>wt</sup></italic>
###xml 632 642 622 628 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/&#916;5-13</sup>
###xml 652 659 638 645 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT/LoxP</sup>
###xml 647 659 633 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>WT/LoxP</sup></italic>
###xml 1001 1006 987 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 1006 1015 992 997 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 1134 1136 1116 1118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 1129 1136 1111 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>wt</sup></italic>
###xml 1136 1146 1118 1124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/&#916;5-13</sup>
###xml 105 110 <span type="species:ncbi:10090">mouse</span>
###xml 154 157 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 422 427 <span type="species:ncbi:10090">mouse</span>
###xml 660 664 <span type="species:ncbi:10090">mice</span>
###xml 1147 1152 <span type="species:ncbi:10090">mouse</span>
A) Histochemical detection of beta-galactosidase expression in tissue sections of ovaries of a wild type mouse that received intrabursal injection of Ad5-CMV-LacZ show staining of the ovarian surface epithelium and absence of staining of the underlying ovarian cortex (panels a and b). Occasional beta-galactosidase positive cells were also observed in fallopian tube (panel c) while no staining was observed in a control mouse injected with PBS (panel d). Scale bars in each image represent 100 microm. B) PCR amplification of LoxP containing sites in introns 4 (top) and 13 (bottom) of Brca1 in Brca1LoxP/LoxP, Brca1wt/wt, Brca1wt/Delta5-13 and Brca1WT/LoxP mice. Genomic DNA was isolated after digestion with proteinase K from the following tissues: liv-liver, t-tail, ut-uterus, ov 30'-ovary after 30 minute digestion and ov 12 h-ovary after 12 hours of digestion. The sizes of the LoxP flanked and wild type (wt) intron 4 and 13 PCR products are indicated. C) PCR amplification of 594 nt excised Brca1Delta5-13 allele was detected only in the ovary exposed to digestion for 30 minutes and in the genomic DNA isolated from a Brca1wt/Delta5-13 mouse.
###end p 15
###begin title 16
###xml 46 51 46 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
Cre-LoxP-Mediated Conditional Inactivation of Brca1
###end title 16
###begin p 17
###xml 114 123 114 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 109 123 109 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup></italic>
###xml 420 429 420 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 415 429 415 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup></italic>
###xml 878 883 878 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 958 967 958 967 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 953 967 953 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup></italic>
###xml 1153 1162 1153 1162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 1148 1162 1148 1162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup></italic>
###xml 1169 1178 1169 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008404-g001">Figure 1B</xref>
###xml 1211 1220 1211 1216 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 1206 1220 1206 1216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>&#916;5-13</sup></italic>
###xml 1390 1399 1386 1395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008404-g001">Figure 1C</xref>
###xml 1515 1520 1511 1516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 1574 1583 1570 1575 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 1569 1583 1565 1575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>&#916;5-13</sup></italic>
###xml 1635 1644 1627 1636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008404-g001">Figure 1C</xref>
###xml 30 33 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 124 128 <span type="species:ncbi:10090">mice</span>
###xml 167 170 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 430 434 <span type="species:ncbi:10090">mice</span>
###xml 1163 1167 <span type="species:ncbi:10090">mice</span>
###xml 1465 1468 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1668 1671 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
To confirm infection with Ad5-CMV-Cre and tissue-restricted Cre-mediated excision of LoxP-flanked sequences, Brca1LoxP/LoxP mice received intrabursal injection of Ad5-CMV-Cre and were euthanized one week post-surgery and the ovaries, uterus and liver were excised. Because the OSE is a comparatively small component of the total ovary, detection of Cre-mediated excision of LoxP flanked sequences in the ovaries of Brca1LoxP/LoxP mice would likely be obscured if genomic DNA from the entire ovary was used for PCR amplification and detection of excision. To circumvent this issue, we prepared a tissue lysate enriched for digested OSE by limiting the initial digestion time of ovary specimens to 30 min. The remainder of the undigested ovary was then digested overnight. Genomic DNA was isolated from each tissue and PCR amplified using both the forward and reverse primers for Brca1 introns 4 and 13. Cre-mediated excision of LoxP-flanked sequences of Brca1LoxP/LoxP was detected by amplification with Brca1-int4-Fwd and Brca1-int13-Rev primers. As expected, PCR amplification resulted in detection of LoxP flanked sequences in all tissues of the Brca1LoxP/LoxP mice (Figure 1B). Importantly, the excised Brca1Delta5-13 product was detected only after short (30 min) digestion of the ovary and not in the liver, uterus or the remainder of the ovary specimens that were digested overnight (Figure 1C). These results confirm successful infection of the ovary by Ad5-CMV-Cre and Cre-mediated excision of LoxP-flanked Brca1 sequences. Moreover, the absence of the excised Brca1Delta5-13 product in the ovary specimens digested overnight (Figure 1C) suggests that the Ad5-CMV-Cre infection is limited to the outer part of the ovary (the OSE) without substantial penetration of the ovarian cortex or infection of uterus or other peritoneal organs.
###end p 17
###begin p 18
###xml 222 231 222 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 217 231 217 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup></italic>
###xml 239 248 239 248 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 236 248 236 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>LoxP/LoxP</sup></italic>
###xml 258 267 258 267 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 271 280 271 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 253 280 253 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup>;p53<sup>LoxP/LoxP</sup></italic>
###xml 290 299 290 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 303 309 303 309 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/515A</sup>
###xml 285 309 285 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup>;p53<sup>+/515A</sup></italic>
###xml 322 331 322 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 335 344 335 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/515A</sup>
###xml 317 344 317 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup>;p53<sup>LoxP/515A</sup></italic>
###xml 503 510 503 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008404-t001">Table 1</xref>
###xml 93 96 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 112 115 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 163 166 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
###xml 366 370 <span type="species:ncbi:10090">mice</span>
###xml 422 425 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Based on the successful demonstration of efficient, tissue-restricted infection with the Ad5-CMV-ntLacZ and Ad5-CMV-Cre viruses, we commenced with intrabursal Ad5-CMV-Cre injection of the following groups of mice: 1) Brca1LoxP/LoxP, 2) p53LoxP/LoxP, 3) Brca1LoxP/LoxP;p53LoxP/LoxP, 4) Brca1LoxP/LoxP;p53+/515A and 5) Brca1LoxP/LoxP;p53LoxP/515A. The total number of mice receiving bilateral or unilateral injection of Ad5-CMV-Cre or unilateral injection of PBS (control) for each group is summarized in Table 1.
###end p 18
###begin title 19
###xml 66 69 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Summary of tumor incidence following intrabursal injection of Ad5-CMV-Cre recombinase.
###end title 19
###begin p 20
Confirmed by PCR amplification of excised product.
###end p 20
###begin p 21
Accrual terminated based on results from prior groups.
###end p 21
###begin title 22
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 29 32 29 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
Conditional Loss of Brca1 or p53 Alone Infrequently Results in Ovarian Tumor Formation
###end title 22
###begin p 23
###xml 19 28 19 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 14 28 14 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup></italic>
###xml 54 61 54 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008404-t001">Table 1</xref>
###xml 66 75 66 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008404-g002">Figure 2A</xref>
###xml 538 545 538 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008404-t001">Table 1</xref>
###xml 682 691 680 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008404-g002">Figure 2A</xref>
###xml 1198 1203 1196 1201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 1255 1264 1253 1258 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 1250 1264 1248 1258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>&#916;5-13</sup></italic>
###xml 1296 1305 1290 1295 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 1291 1305 1285 1295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>&#916;5-13</sup></italic>
###xml 1384 1393 1374 1383 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 1379 1393 1369 1383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup></italic>
###xml 1400 1407 1390 1397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008404-t001">Table 1</xref>
###xml 1541 1550 1531 1540 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 1536 1550 1526 1540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup></italic>
###xml 1664 1668 1654 1658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Chodankar1">[22]</xref>
###xml 1670 1674 1660 1664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-ClarkKnowles1">[23]</xref>
###xml 1676 1680 1666 1670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Xing1">[25]</xref>
###xml 1716 1721 1706 1711 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 29 33 <span type="species:ncbi:10090">mice</span>
###xml 91 95 <span type="species:ncbi:10090">mice</span>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
###xml 173 176 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 318 322 <span type="species:ncbi:10090">mice</span>
###xml 394 398 <span type="species:ncbi:10090">mice</span>
###xml 405 409 <span type="species:ncbi:10090">mice</span>
###xml 444 447 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 476 480 <span type="species:ncbi:10090">mice</span>
###xml 607 610 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 741 745 <span type="species:ncbi:10090">mice</span>
###xml 793 798 <span type="species:ncbi:10090">mouse</span>
###xml 892 895 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1394 1398 <span type="species:ncbi:10090">mice</span>
###xml 1780 1785 <span type="species:ncbi:10090">mouse</span>
A total of 51 Brca1LoxP/LoxP mice were evaluated (see Table 1 and Figure 2A), including 40 mice that received bilateral and 5 mice that received unilateral injection of Ad5-CMV-Cre as well as 6 unilateral PBS injected controls. The reproductive tracts and pathologically altered organs were isolated from all of these mice and subjected to histopathological evaluation (by L.H.E.). Of these 51 mice, 9/40 mice (23%) that received bilateral Ad5-CMV-Cre injection and 1/6 (17%) mice that received unilateral PBS injection developed tumors (Table 1) after long latency (i.e., average = 491+/-26 days after Ad5-CMV-Cre injection). No ovarian or reproductive tract tumors were detected (Figure 2A), and 8/9 tumors arising in bilaterally injected mice and the single tumor arising in a PBS injected mouse were extra-peritoneal. Because the tumors were located at sites distant from the site of Ad5-CMV-Cre injection, we considered the possibility that intrabursal injection of virus was leaky resulting in local or systemic infection beyond the original site of injection. To test this experimentally, genomic DNA was isolated from each of these tumors and subjected to PCR amplification of LoxP-flanked Brca1 sequences in introns 4 and 13 and the excised Brca1Delta5-13 product. Importantly, the Brca1Delta5-13 excision product was not detected in any of the tumors identified in the Brca1LoxP/LoxP mice (Table 1 and data not shown). These results suggest that the tumors observed were sporadic and unrelated to the Cre-mediated excision of Brca1LoxP/LoxP resulting from local or systemic viral infection. The lack of ovarian tumors is consistent with previous studies [22], [23], [25] demonstrating that inactivation of Brca1 alone is insufficient for malignant transformation in the mouse ovary.
###end p 23
###begin title 24
###xml 123 128 123 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 136 139 136 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
Incidence and latency of reproductive tract tumors in female mice with conditional inactivation of LoxP flanked alleles of Brca1 and/or p53.
###end title 24
###begin p 25
###xml 134 139 134 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 139 148 139 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 149 152 145 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 152 161 148 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 169 178 161 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 166 178 158 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>&#916;2-10</sup></italic>
###xml 230 235 218 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 240 243 228 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 272 277 260 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 277 286 265 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 287 290 271 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 290 299 274 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 390 393 370 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 434 443 414 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 431 443 411 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>&#916;2-10</sup></italic>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
A) Fraction of tumor free mice after intrabursal injection of Adenovirus-Cre recombinase. B) Genotyping analysis of DNA isolated from Brca1Delta5-13;p53Delta2-10 and p53Delta2-10 ovarian tumors. Both the Lox P flanked and excised Brca1 and p53 alleles were amplified from Brca1Delta5-13;p53Delta2-10 tumors (cases 307, 350, 352 355, 397, 399, 411 and 412) and the Lox P flanked and excised p53 allele was amplified from the single p53Delta2-10 ovarian tumor (case 627). In each panel the left lane contains a DNA ladder and the sizes of the amplified products (nt) are indicated at the right.
###end p 25
###begin p 26
###xml 13 22 13 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 10 22 10 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>LoxP/LoxP</sup></italic>
###xml 182 189 182 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008404-t001">Table 1</xref>
###xml 342 349 342 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008404-t001">Table 1</xref>
###xml 354 363 354 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008404-g002">Figure 2A</xref>
###xml 836 845 836 841 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 833 845 833 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>&#916;2-10</sup></italic>
###xml 855 864 851 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008404-g002">Figure 2B</xref>
###xml 1043 1046 1039 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1170 1174 1166 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-FleskenNikitin1">[19]</xref>
###xml 1315 1318 1311 1314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 23 27 <span type="species:ncbi:10090">mice</span>
###xml 128 131 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 225 229 <span type="species:ncbi:10090">mice</span>
###xml 293 297 <span type="species:ncbi:10090">mice</span>
###xml 319 322 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 336 340 <span type="species:ncbi:10090">mice</span>
###xml 384 389 <span type="species:ncbi:10090">mouse</span>
###xml 459 462 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 482 487 <span type="species:ncbi:10090">mouse</span>
###xml 593 596 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 618 623 <span type="species:ncbi:10090">mouse</span>
Among the p53LoxP/LoxP mice evaluated in this study (n = 53), 41 received bilateral and 6 received unilateral injections of Ad5-CMV-Cre and 6 received unilateral injection with PBS (Table 1). None of the control PBS injected mice developed tumors, but a low frequency of tumor formation (3/53 mice) was observed in Ad5-CMV-Cre injected mice (Table 1 and Figure 2A). Specifically, one mouse developed a large palpable ovarian mass 132 days after bilateral Ad5-CMV-Cre injection, one mouse developed a small mass at the end of one of the uterine horns 373 days after unilateral injection of Ad5-CMV-Cre, and one control mouse developed a palpable subcutaneous mass located near the scapulae 353 days after PBS injection. Analysis of the genomic DNA isolated from the ovarian and uterine tumors resulted in amplification of the excised p53Delta2-10 product (Figure 2B and data not shown), whereas no excision product was amplified from the DNA isolated from the subcutaneous scapular tumor. These results suggest that conditional inactivation of p53 alone rarely results in ovarian tumor development (1/47 cases, 2%). This finding is again consistent with a previous study [19] reporting low frequency of ovarian tumor development (2/31 cases, 6%) after intrabursal Adenovirus-cre mediated conditional inactivation of p53.
###end p 26
###begin title 27
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 35 38 35 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
Conditional Loss of Both Brca1 and p53 Cooperates to Induce Ovarian Tumors
###end title 27
###begin p 28
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 52 55 52 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 159 168 159 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 172 181 172 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 154 181 154 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup>;p53<sup>LoxP/LoxP</sup></italic>
###xml 188 197 188 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 201 207 201 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/515A</sup>
###xml 183 207 183 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup>;p53<sup>+/515A</sup></italic>
###xml 217 226 217 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 230 239 230 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/515A</sup>
###xml 212 239 212 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup>;p53<sup>LoxP/515A</sup></italic>
###xml 329 333 329 333 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">515A</sup>
###xml 326 333 326 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>515A</sup></italic>
###xml 450 453 450 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 478 482 478 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Lang1">[27]</xref>
###xml 549 558 549 558 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">515A/515A</sup>
###xml 546 558 546 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>515A/515A</sup></italic>
###xml 684 687 684 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 702 706 702 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Harvey1">[32]</xref>
###xml 708 712 708 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Jacks1">[33]</xref>
###xml 766 775 766 775 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 779 785 779 785 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/515A</sup>
###xml 761 785 761 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup>;p53<sup>+/515A</sup></italic>
###xml 795 804 795 804 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 808 817 808 817 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/515A</sup>
###xml 790 817 790 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup>;p53<sup>LoxP/515A</sup></italic>
###xml 240 244 <span type="species:ncbi:10090">mice</span>
###xml 284 287 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 334 338 <span type="species:ncbi:10090">mice</span>
###xml 484 488 <span type="species:ncbi:10090">mice</span>
###xml 697 701 <span type="species:ncbi:10090">mice</span>
###xml 818 822 <span type="species:ncbi:10090">mice</span>
To determine whether inactivation of both Brca1 and p53 in the OSE can cooperate to induce ovarian tumorigenesis, we evaluated ovarian tumor formation in Brca1LoxP/LoxP;p53LoxP/LoxP, Brca1LoxP/LoxP;p53+/515A and Brca1LoxP/LoxP;p53LoxP/515A mice following intrabursal injection of Ad5-CMV-Cre. It is important to note that the p53515A mice used in the current study constitutively expressed the arginine to histidine substitution at amino acid 172 of p53. As previously reported [27], mice harboring the homozygous constitutively expressed mutant p53515A/515A allele developed tumors with an incidence, latency and spectrum (e.g., lymphomas and sarcomas) similar to that of homozygous p53 knockout mice [32], [33]. Ovarian tumors were not detected in any of the Brca1LoxP/LoxP;p53+/515A and Brca1LoxP/LoxP;p53LoxP/515A mice at the time of euthanasia; therefore, these two groups were not informative for this study.
###end p 28
###begin p 29
###xml 19 28 19 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 32 41 32 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 14 41 14 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup>;p53<sup>LoxP/LoxP</sup></italic>
###xml 208 215 208 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008404-t001">Table 1</xref>
###xml 335 342 335 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008404-t001">Table 1</xref>
###xml 347 356 347 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008404-g002">Figure 2A</xref>
###xml 464 473 462 471 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 477 486 475 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 459 486 457 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup>;p53<sup>LoxP/LoxP</sup></italic>
###xml 600 609 598 607 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 595 609 593 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup></italic>
###xml 616 625 614 623 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 613 625 611 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>LoxP/LoxP</sup></italic>
###xml 785 794 783 792 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 780 794 778 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup></italic>
###xml 802 811 800 809 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 799 811 797 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>LoxP/LoxP</sup></italic>
###xml 825 832 823 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008404-t002">Table 2</xref>
###xml 834 843 832 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008404-g002">Figure 2B</xref>
###xml 917 926 915 924 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 930 939 928 937 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 912 939 910 937 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup>;p53<sup>LoxP/LoxP</sup></italic>
###xml 1069 1076 1067 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008404-t002">Table 2</xref>
###xml 1329 1338 1327 1332 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 1324 1338 1322 1332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>&#916;5-13</sup></italic>
###xml 1346 1355 1340 1345 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 1343 1355 1337 1345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>&#916;2-10</sup></italic>
###xml 1501 1506 1491 1496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 1511 1514 1501 1504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
###xml 102 105 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 147 150 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 179 183 <span type="species:ncbi:10090">mice</span>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
###xml 288 292 <span type="species:ncbi:10090">mice</span>
###xml 326 329 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 402 405 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 487 491 <span type="species:ncbi:10090">mice</span>
###xml 626 630 <span type="species:ncbi:10090">mice</span>
###xml 940 944 <span type="species:ncbi:10090">mice</span>
A total of 47 Brca1LoxP/LoxP;p53LoxP/LoxP mice were evaluated. Among these, 35 received bilateral Ad5-CMV-Cre injection, 6 received unilateral Ad5-CMV-Cre injection and 6 control mice were injected with PBS (Table 1). Tumors were detected in 20/35 (57%) mice with bilateral and 4/6 (66%) mice with unilateral injection of Ad5-CMV-Cre (Table 1 and Figure 2A) after long latency (409+/-81 days after Ad5-CMV-Cre injection). Pair-wise log-rank tests showed that Brca1LoxP/LoxP;p53LoxP/LoxP mice had significantly shorter average survival after conditional inactivation of LoxP flanked alleles than Brca1LoxP/LoxP or p53LoxP/LoxP mice (p<0.000001 and p<0.05 respectively). Among the 24 total tumors, we were able to demonstrate Cre-mediated excision of LoxP flanked sequences of both Brca1LoxP/LoxP and p53LoxP/LoxP in 23 cases (Table 2, Figure 2B and data not shown). The majority (22/23) of the tumors detected in Brca1LoxP/LoxP;p53LoxP/LoxP mice were associated with the ovaries and reproductive tract, and all exhibited Cre-mediated excision of LoxP flanked sequences (Table 2). Among these, there were 7 leiomyosarcomas of the ovary, 4 leiomyosarcomas of the ovary and uterus, 8 ovarian sarcomas, one malignant teratoma, one sclerosing stromal tumor of the uterus and one uterine adenocarcinoma. The only case in which the Brca1Delta5-13 and p53Delta2-10 excision products were not detected was a peritoneal sarcoma that was not associated with the reproductive tract. Thus, conditional loss of both Brca1 and p53 in the ovary leads to a high frequency of ovarian and reproductive tract tumor formation.
###end p 29
###begin title 30
###xml 63 68 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 76 79 76 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
Summary of tumors associated with Cre-mediated inactivation of Brca1 and/or p53.
###end title 30
###begin title 31
###xml 84 89 84 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 97 100 97 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 48 52 <span type="species:ncbi:10090">Mice</span>
Histopathological Features of Tumors Arising in Mice with Conditionally Inactivated Brca1 and/or p53
###end title 31
###begin p 32
###xml 104 113 104 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 99 113 99 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup></italic>
###xml 338 347 338 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 333 347 333 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>&#916;5-13</sup></italic>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
###xml 545 549 <span type="species:ncbi:10090">mice</span>
With the exception of one unclassifiable necrotic peritoneal mass, all of the tumors identified in Brca1LoxP/LoxP mice were classified as carcinomas. Among these was one vaginal squamous carcinoma, two subcutaneous adenocarcinomas located near the scapulae and five lung adenocarcinomas (not shown). PCR amplification of the excised Brca1Delta5-13 product was not detected in any of these cases leading to the conclusion that these carcinomas were sporadic in nature. The relatively high frequency of sporadic tumor occurrence in this strain of mice remains unexplained.
###end p 32
###begin p 33
###xml 32 36 32 36 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Chodankar1">[22]</xref>
###xml 38 42 38 42 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-ClarkKnowles1">[23]</xref>
###xml 85 94 85 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 80 94 80 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup></italic>
###xml 269 278 269 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 264 278 264 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup></italic>
###xml 462 467 460 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 63 66 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
###xml 279 283 <span type="species:ncbi:10090">mice</span>
###xml 324 327 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
In contrast to previous studies [22], [23], the ovaries of Ad5-CMV-Cre injected Brca1LoxP/LoxP mice were histologically unremarkable and did not exhibit noteworthy morphological or histological changes of the OSE indicative of pre-neoplastic or neoplastic growth. Brca1LoxP/LoxP mice that received bilateral intrabursal Ad5-CMV-Cre injections were observed for an average of 475 days (+/-102 days) prior to euthanasia suggesting that conditional inactivation of Brca1 alone is insufficient to cause ovarian tumors even after long latency.
###end p 33
###begin p 34
###xml 73 82 73 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 70 82 70 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>LoxP/LoxP</sup></italic>
###xml 187 196 187 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008404-g003">Figure 3A</xref>
###xml 451 460 451 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 464 473 464 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 446 473 446 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup>;p53<sup>LoxP/LoxP</sup></italic>
###xml 568 577 568 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 563 577 563 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>&#916;5-13</sup></italic>
###xml 581 590 577 582 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 578 590 574 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>&#916;2-10</sup></italic>
###xml 1000 1009 992 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008404-g003">Figure 3A</xref>
###xml 1114 1123 1106 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008404-g003">Figure 3A</xref>
###xml 1198 1207 1190 1199 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 1195 1207 1187 1199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>LoxP/LoxP</sup></italic>
###xml 1235 1244 1227 1236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008404-g003">Figure 3A</xref>
###xml 1503 1512 1483 1492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008404-g003">Figure 3B</xref>
###xml 1579 1584 1559 1564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 1589 1592 1569 1572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 83 88 <span type="species:ncbi:10090">mouse</span>
###xml 116 119 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 474 478 <span type="species:ncbi:10090">mice</span>
###xml 507 510 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 538 542 <span type="species:ncbi:10090">mice</span>
Histopathological evaluation of the single ovarian mass detected in a p53LoxP/LoxP mouse that received bilateral Ad-CMV-Cre injection showed that the tumor was an ovarian leiomyosarcoma (Figure 3A). The tumor was composed of spindle cells with marked cytologic atypia and numerous mitotic figures, including abnormal mitotic figures. The only other tumor detected in this group was a small uterine mass classified as a uterine leiomyosarcoma. In Brca1LoxP/LoxP;p53LoxP/LoxP mice that received bilateral Ad5-CMV-Cre injection, 23/41 (56%) mice developed confirmed Brca1Delta5-13;p53Delta2-10-associated tumors, most of which were ovarian. Among the ovarian tumors, the majority were categorized as soft tissue tumors including ovarian leiomyosarcomas (n = 12) and high grade sarcomas that could not be further classified (n = 4). These leiomyosarcomas exhibited spindle cells with marked atypia and the high grade sarcomas demonstrated pleiomorphic atypia without other specific morphologic features (Figure 3A). The ovarian tumors identified were highly proliferative as evidenced by nearly uniform PCNA staining (Figure 3A, panels c, g, and k) and, consistent with Cre-mediated inactivation of p53LoxP/LoxP, lacked expression of p53 (Figure 3A, panels d, h, and l). The ovarian tumors also lacked histopathological features or immunohistochemical staining of granulosa cell (alpha-inhibin), epithelial (CK8 and CK 19), lymphoid (CD3 and CD45R) or alpha-smooth muscle actin (alpha-SMA) differentiation (Figure 3B and data not shown). Thus, while conditional inactivation of both Brca1 and p53 resulted in a high frequency of ovarian tumor development, no ovarian carcinomas were detected.
###end p 34
###begin title 35
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 69 78 69 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 79 82 75 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 82 91 78 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 99 108 91 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 96 108 88 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>&#916;2-10</sup></italic>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 154 157 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Histopathological characterization of ovarian tumors arising in Brca1Delta5-13;p53Delta2-10 and p53Delta2-10 mice after intrabursal administration of Ad5-CMV-Cre.
###end title 35
###begin p 36
###xml 124 129 124 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 129 138 129 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 139 142 135 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 142 151 138 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 220 229 212 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 217 229 209 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>&#916;2-10</sup></italic>
###xml 594 597 582 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 641 646 629 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 646 655 634 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 656 659 640 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 659 668 643 648 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 152 156 <span type="species:ncbi:10090">mice</span>
###xml 230 235 <span type="species:ncbi:10090">mouse</span>
A) Low (panels a, e, and i) and high (panels b, f, and j) magnification of H&E stained sections of tumors isolated from two Brca1Delta5-13;p53Delta2-10 mice (cases number 307, panels a-d, and 399, panels e-h) and one p53Delta2-10 mouse (case number 627, panels i-l). Immunohistochemical detection of proliferating cell nuclear antigen (PCNA) shows that all three tumors were highly proliferative (panels c, g, and k). Immunohistochemical staining for p53 (Panels d, h, and l) showing that none of the tumors express p53 protein, consistent with the conditional inactivation of the LoxP-flanked p53 allele. B) Immunohistochemical staining of Brca1Delta5-13;p53Delta2-10 case number 307, a representative tumor, shows that the tumor is highly proliferative (PCNA staining, panel a), but does not express other common differentiation markers. Immunostaining for alpha-inhibin (panel b) shows isolated positively staining follicular cells and little or no staining of the tumor cells. Similarly, immunohistochemical detection of markers of lymphoid (CD45, panel c) epithelial (cytokeratins 8 and 19, panels d and e respectively) and stromal (alpha-smooth muscle actin, panel f) differentiation are not detected in tumor cells. Scale bars in each image represent 100 microm.
###end p 36
###begin title 37
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 10 13 10 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
Brca1 and p53 Tumors Exhibit Genomic Instability
###end title 37
###begin p 38
###xml 40 49 40 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 37 49 37 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>&#916;2-10</sup></italic>
###xml 95 104 91 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 90 104 86 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>&#916;5-13</sup></italic>
###xml 108 117 100 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 105 117 97 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>&#916;2-10</sup></italic>
###xml 229 238 217 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 226 238 214 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>&#916;2-10</sup></italic>
###xml 422 431 406 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008404-g004">Figure 4A</xref>
###xml 458 467 442 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 453 467 437 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>&#916;5-13</sup></italic>
###xml 471 480 451 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 468 480 448 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>&#916;2-10</sup></italic>
###xml 729 738 705 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008404-g004">Figure 4A</xref>
###xml 863 872 839 844 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 858 872 834 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>&#916;5-13</sup></italic>
###xml 876 885 848 853 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 873 885 845 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>&#916;2-10</sup></italic>
###xml 1029 1038 997 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008404-g004">Figure 4B</xref>
###xml 1665 1674 1633 1638 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 1660 1674 1628 1638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>&#916;5-13</sup></italic>
###xml 1767 1772 1731 1736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 1839 1844 1803 1808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 1729 1733 <span type="species:ncbi:10090">mice</span>
Genomic DNA isolated from the single p53Delta2-10 ovarian leiomyosarcoma and two cases of Brca1Delta5-13;p53Delta2-10 ovarian leiomyosarcomas was subjected to array based comparative genomic hybridization (aCGH) analysis. The p53Delta2-10 ovarian leiomyosarcoma (case number 627) exhibited gains and/or losses of entire chromosomes analogous with aneuploidy and occasional isolated regions of DNA copy number alterations (Figure 4A). By comparison, the Brca1Delta5-13;p53Delta2-10 ovarian leiomyosarcomas (case numbers 307 and 399) exhibited a much more complex array of genetic copy number alterations including entire chromosomal gains and losses as well as distinct regions of DNA gains and losses within the same chromosome (Figure 4A); results suggestive of a high degree of chromosomal damage. Karyotypic analysis of a tumor cell line established from Brca1Delta5-13;p53Delta2-10 ovarian leiomyosarcoma case number 399 supported this observation. A total of 26 metaphase spreads were analyzed, 22 of which were karyotyped (Figure 4B). The number of chromosomes per individual metaphase ranged from 65 to 143, with no clear modal number. However, 18 metaphases were near-tetraploid, with chromosome counts ranging from 65-87. Seven metaphases had counts ranging from 97-143. The remaining metaphases showed a high level of chromosomal damage with many fragments, double minutes and a tri-radial rearrangement. Four of the metaphases had 1-3 chromosome or chromatid breaks, and 18 metaphases had one or more small markers or fragments. Thus, the cytogenetic analysis of this tumor cell line revealed considerable genomic instability. Due to the absence of Brca1Delta5-13 tumors were unable to assess chromosomal stability in mice with conditional inactivation of Brca1 alone; however, these results support the hypothesis that loss of Brca1 function leads to a high degree of genetic instability thus contributing to ovarian tumorigenesis.
###end p 38
###begin title 39
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 5 14 5 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 15 18 11 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 18 27 14 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
Brca1Delta5-13;p53Delta2-10 tumors exhibit a high degree of genomic instability.
###end title 39
###begin p 40
###xml 95 98 95 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 98 107 98 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 124 129 120 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 129 138 125 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 139 142 131 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 142 151 134 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 210 213 198 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 213 222 201 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 282 287 266 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 287 296 271 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 297 300 277 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 300 309 280 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 561 566 537 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 566 575 542 547 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 576 579 548 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 579 588 551 556 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
A) Array based comparative genomic hybridization was performed using genomic DNA isolated from p53Delta2-10 (case #627) and Brca1Delta5-13;p53Delta2-10 (cases #307 and #399) ovarian tumors and shows that while p53Delta2-10 tumors exhibit alterations consistent with aneuploidy, the Brca1Delta5-13;p53Delta2-10 ovarian tumors exhibit complex patterns of chromosomal copy number changes, with gains and losses apparent within the same chromosome. B) The high degree of genetic instability was verified by metaphase chromosome analysis of a cell line derived from Brca1Delta5-13;p53Delta2-10 tumor #399.
###end p 40
###begin title 41
Discussion
###end title 41
###begin p 42
###xml 105 110 105 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 158 163 158 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 221 225 221 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Chodankar1">[22]</xref>
###xml 227 231 227 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-ClarkKnowles1">[23]</xref>
###xml 233 237 233 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Xing1">[25]</xref>
###xml 271 275 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Buller1">[11]</xref>
###xml 277 281 277 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Ramus1">[12]</xref>
###xml 283 287 283 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Rhei1">[13]</xref>
###xml 289 293 289 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Schorge1">[14]</xref>
###xml 331 336 331 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 378 381 378 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 573 578 573 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 585 588 585 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 601 605 601 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Brodie1">[15]</xref>
###xml 636 641 636 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 646 649 646 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 820 825 820 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 830 833 830 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 72 77 <span type="species:ncbi:9606">women</span>
###xml 132 136 <span type="species:ncbi:10090">mice</span>
###xml 425 430 <span type="species:ncbi:10090">mouse</span>
###xml 530 534 <span type="species:ncbi:10090">mice</span>
###xml 692 698 <span type="species:ncbi:9606">humans</span>
###xml 735 739 <span type="species:ncbi:10090">mice</span>
###xml 759 764 <span type="species:ncbi:10090">mouse</span>
Although the lifetime risk of developing ovarian cancer is increased in women with germline mutations of BRCA1, previous studies in mice suggest that loss of Brca1 alone was insufficient to lead to the development of EOC [22], [23], [25]. A number of independent studies [11], [12], [13], [14] have shown that in cases of EOC with BRCA1 mutations, the frequency of mutations of p53 is high, ranging from 70-90%. Moreover, in mouse models of mammary cancer, tumor latency is decreased and incidence of tumor formation increased in mice with both conditional inactivation of Brca1 and a p53 null allele [15]. This apparent cooperation of Brca1 and p53 in inherited breast and ovarian cancer in humans and in mammary tumor development in mice led us to create a mouse model of ovarian cancer by conditional inactivation of Brca1 and p53 in the ovarian epithelium.
###end p 42
###begin p 43
###xml 39 42 39 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 118 122 118 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Jacks1">[33]</xref>
###xml 124 128 124 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Donehower1">[34]</xref>
###xml 254 258 254 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Lang1">[27]</xref>
###xml 260 264 260 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Olive1">[35]</xref>
###xml 339 342 339 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 417 420 417 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 544 547 544 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 614 617 614 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 633 637 633 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Lang1">[27]</xref>
###xml 639 643 639 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Olive1">[35]</xref>
###xml 684 689 684 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 695 698 695 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 780 783 780 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 880 889 880 889 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 877 889 877 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>LoxP/LoxP</sup></italic>
###xml 915 924 915 924 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 910 924 910 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup></italic>
###xml 1079 1082 1079 1082 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1196 1200 1196 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Lang1">[27]</xref>
###xml 1202 1206 1202 1206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Olive1">[35]</xref>
###xml 1284 1287 1284 1287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1292 1296 1292 1296 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">515A</sup>
###xml 1289 1296 1289 1296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>515A</sup></italic>
###xml 1315 1318 1315 1318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1359 1363 1359 1363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Lang1">[27]</xref>
###xml 1390 1399 1390 1399 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 1385 1399 1385 1399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup></italic>
###xml 1510 1515 1510 1515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 1519 1522 1519 1522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1583 1587 1583 1587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-FleskenNikitin1">[19]</xref>
###xml 1589 1593 1589 1593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Chodankar1">[22]</xref>
###xml 1595 1599 1595 1599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-ClarkKnowles1">[23]</xref>
###xml 1601 1605 1601 1605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Xing1">[25]</xref>
###xml 1662 1667 1662 1667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 1672 1675 1672 1675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1790 1796 1790 1796 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/515A</sup>
###xml 1787 1796 1787 1796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>+/515A</sup></italic>
###xml 1883 1886 1883 1886 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1880 1886 1880 1886 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>+/&#8722;</sup></italic>
###xml 1892 1896 1892 1896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Lang1">[27]</xref>
###xml 1992 1997 1992 1997 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 2178 2183 2178 2183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 2265 2274 2265 2274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 2278 2284 2278 2284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/515A</sup>
###xml 2260 2284 2260 2284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup>;p53<sup>+/515A</sup></italic>
###xml 2294 2303 2294 2303 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 2307 2316 2307 2316 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/515A</sup>
###xml 2289 2316 2289 2316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup>;p53<sup>LoxP/515A</sup></italic>
###xml 2620 2624 2620 2624 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">515A</sup>
###xml 2617 2624 2617 2624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>515A</sup></italic>
###xml 2719 2725 2719 2725 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/515A</sup>
###xml 2716 2725 2716 2725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>+/515A</sup></italic>
###xml 2732 2741 2732 2741 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/515A</sup>
###xml 2729 2741 2729 2741 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>LoxP/515A</sup></italic>
###xml 2835 2844 2835 2844 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 2848 2854 2848 2854 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/515A</sup>
###xml 2830 2854 2830 2854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup>;p53<sup>+/515A</sup></italic>
###xml 2864 2873 2864 2873 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 2877 2886 2877 2886 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/515A</sup>
###xml 2859 2886 2859 2886 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup>;p53<sup>LoxP/515A</sup></italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 275 279 <span type="species:ncbi:10090">mice</span>
###xml 403 407 <span type="species:ncbi:10090">mice</span>
###xml 669 674 <span type="species:ncbi:10090">mouse</span>
###xml 1238 1243 <span type="species:ncbi:10090">mouse</span>
###xml 1345 1350 <span type="species:ncbi:9606">human</span>
###xml 1736 1740 <span type="species:ncbi:10090">mice</span>
###xml 1761 1765 <span type="species:ncbi:10090">mice</span>
###xml 1887 1891 <span type="species:ncbi:10090">mice</span>
###xml 1922 1926 <span type="species:ncbi:10090">mice</span>
###xml 2317 2321 <span type="species:ncbi:10090">mice</span>
###xml 2410 2414 <span type="species:ncbi:10090">mice</span>
###xml 2430 2434 <span type="species:ncbi:10090">mice</span>
###xml 2486 2490 <span type="species:ncbi:10090">mice</span>
###xml 2555 2558 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 2665 2669 <span type="species:ncbi:10090">mice</span>
###xml 2887 2891 <span type="species:ncbi:10090">mice</span>
Mice that are null or heterozygous for p53 are highly prone to developing tumors, particularly lymphomas and sarcomas [33], [34]. For reasons that are not completely understood, the occurrence of epithelial tumors is relatively rare. More recent studies [27], [35] show that mice that have homozygous or heterozygous missense mutations of p53 develop tumors with similar latency and spectrum to that of mice that are p53 null or heterozygous, but that they also develop osteosarcomas and carcinomas with higher frequency. Missense mutations of p53 have been shown to confer gain-of-function phenotypes compared to p53 null mutations [27], [35]. Therefore, to develop a mouse model of Brca1- and p53-associated inherited EOC, we used two approaches for inactivation or mutation of p53. First, we predicted that using a strategy for tissue-restricted conditional inactivation of p53LoxP/LoxP in combination with Brca1LoxP/LoxP in the OSE would result in predisposition for the development of ovarian carcinomas. The second approach was based on the idea that missense mutations of p53 confer gain-of-function phenotypes and possibly alter tissue specificity, favoring the development of carcinomas [27], [35]. Therefore, we also employed a mouse model expressing a missense mutation of p53 (p53515A, analogous to the p53 R175H hotspot mutation in human cancers [27]) in conjunction with Brca1LoxP/LoxP. Our results were consistent with previous findings in that ovary-specific conditional inactivation of either Brca1 or p53 alone rarely resulted in the development of invasive tumors [19], [22], [23], [25]. However, Cre-mediated conditional inactivation of both Brca1 and p53 resulted in the development of tumors in 56% (23/41) of the mice evaluated. Although mice heterozygous for the p53+/515A mutant allele develop tumors (i.e., lymphomas or sarcomas) with similar latency to p53+/- mice [27], we hypothesized that in mice that had also undergone Cre-mediated conditional inactivation of Brca1, ovarian carcinoma development might either out-pace or occur coincidentally with tumors at other sites. However, in spite of additional ovary-specific conditional inactivation of Brca1, tumors necessitating euthanasia developed at sites other than the ovary in Brca1LoxP/LoxP;p53+/515A and Brca1LoxP/LoxP;p53LoxP/515A mice. Histopathological evaluation revealed no ovarian or reproductive tract tumors in these mice. The strain of mice used in our study had been previously crossed with mice expressing Cre-recombinase under transcriptional control of the CMV gene promoter resulting in constitutive expression of the p53515A allele. It is therefore unknown whether mice would develop ovarian tumors if expression of p53+/515A or p53LoxP/515A were confined only to the OSE. Our results do suggest that ovarian tumor development in Brca1LoxP/LoxP;p53+/515A and Brca1LoxP/LoxP;p53LoxP/515A mice would require long latency and/or additional genetic alterations.
###end p 43
###begin p 44
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 80 83 80 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Lynch1">[1]</xref>
###xml 129 138 129 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 124 138 124 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>&#916;5-13</sup></italic>
###xml 142 151 138 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 139 151 135 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>&#916;2-10</sup></italic>
###xml 163 172 155 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 160 172 152 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>&#916;2-10</sup></italic>
###xml 365 369 353 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Sood1">[36]</xref>
###xml 538 547 526 535 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 533 547 521 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup></italic>
###xml 551 560 539 548 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 548 560 536 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>LoxP/LoxP</sup></italic>
###xml 1168 1172 1142 1146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Xing1">[25]</xref>
###xml 1186 1193 1160 1167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 1227 1232 1201 1206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 1237 1240 1211 1214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1592 1597 1566 1571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 1602 1605 1576 1579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1756 1759 1730 1733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1798 1802 1772 1776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Jacks1">[33]</xref>
###xml 1804 1808 1778 1782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Donehower1">[34]</xref>
###xml 1843 1852 1817 1826 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 1840 1852 1814 1826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>LoxP/LoxP</sup></italic>
###xml 1884 1887 1858 1861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1985 1988 1959 1962 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 2206 2209 2180 2183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 2209 2218 2183 2192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 2219 2221 2193 2195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 2221 2230 2195 2204 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 2313 2317 2287 2291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-FleskenNikitin1">[19]</xref>
###xml 2424 2427 2398 2401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 39 44 <span type="species:ncbi:9606">women</span>
###xml 310 315 <span type="species:ncbi:9606">women</span>
###xml 561 565 <span type="species:ncbi:10090">mice</span>
###xml 602 605 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 869 872 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1549 1552 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1765 1769 <span type="species:ncbi:10090">mice</span>
###xml 2231 2235 <span type="species:ncbi:10090">mice</span>
###xml 2414 2418 <span type="species:ncbi:10090">mice</span>
BRCA1-associated ovarian carcinomas in women typically exhibit serous histology [1]. Histopathological evaluation of the 22 Brca1Delta5-13;p53Delta2-10 and two p53Delta2-10 reproductive tract tumors unexpectedly showed a complex spectrum of tumors; ovarian leiomyosarcomas and sarcomas were most prevalent. In women, primary ovarian sarcomas are exceptionally rare [36], with very little known regarding the molecular alterations that contribute to their development. The reason for the lack of ovarian adenocarcinoma development in Brca1LoxP/LoxP;p53LoxP/LoxP mice given intrabursal injections of Ad5-CMV-Cre is unclear. Given the demonstration of highly selective ovarian surface epithelium infection after intrabursal administration of adenovirus, it seems unlikely to be due to technical issues associated with the injection procedure. The long latency between Ad5-CMV-Cre administration and the detection of tumors (approximately400+/-100 days) and the high degree of genomic instability detected in tumors by aCGH and karyotyping analysis strongly suggests that additional events are required for ovarian tumorigenesis. This is consistent with previous findings [25] showing that ex vivo conditional inactivation of both Brca1 and p53 in ovarian explants was insufficient for transformation, whereas the addition of Myc cooperated to induce transformation in these cells. One possible explanation for the high incidence of ovarian leiomyosarcomas is that ovarian stromal cells may be coincidentally infected after intrabursal injection of Ad5-CMV-Cre and that the combined loss of both Brca1 and p53 renders this population of cells more susceptible to transformation than the ovarian surface epithelium. Consistent with this is the observation that p53 null mice frequently develop sarcomas [33], [34]. Cre-mediated recombination of p53LoxP/LoxP alleles results in deletion of p53 exons two through ten, thus rendering the cells and tissues undergoing recombination effectively p53 null. Although this may potentially explain the high frequency of ovarian leiomyosarcomas observed, a previous study employing intrabursal adenovirus-Cre-recombinase mediated inactivation of LoxP-flanked sequences in p53LoxP/LoxP;RbLoxP/LoxP mice reported a high prevalence of ovarian carcinomas rather than leiomyosarcomas [19], suggesting the explanation may be more complicated than just relative tissue susceptibility in mice with p53 mutations.
###end p 44
###begin p 45
###xml 110 114 110 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Folkins1">[37]</xref>
###xml 116 120 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Lee1">[38]</xref>
###xml 122 126 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Medeiros1">[39]</xref>
###xml 128 132 128 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Shaw1">[40]</xref>
###xml 194 199 194 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 544 549 544 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 724 729 724 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 824 828 824 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Semmel1">[41]</xref>
###xml 951 956 951 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 961 964 961 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1687 1696 1684 1693 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 1682 1696 1679 1693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup></italic>
###xml 1707 1716 1704 1713 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 1704 1716 1701 1713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>LoxP/LoxP</sup></italic>
###xml 1777 1782 1774 1779 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 1787 1790 1784 1787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 2004 2008 2001 2005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Xing2">[42]</xref>
###xml 2138 2143 2135 2140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 2286 2291 2283 2288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 2403 2418 2400 2415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre-recombinase</italic>
###xml 2532 2563 2529 2560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">oviduct-specific glycoprotein 1</italic>
###xml 2569 2573 2566 2570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Arias1">[43]</xref>
###xml 2575 2579 2572 2576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Woo1">[44]</xref>
###xml 1065 1071 <span type="species:ncbi:10090">murine</span>
###xml 1134 1137 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1393 1396 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1661 1676 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1717 1721 <span type="species:ncbi:10090">mice</span>
###xml 1875 1890 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1927 1931 <span type="species:ncbi:10090">mice</span>
###xml 2260 2265 <span type="species:ncbi:10090">mouse</span>
###xml 2381 2385 <span type="species:ncbi:10090">mice</span>
An alternative explanation for the lack of epithelial cancers in this model comes from several recent studies [37], [38], [39], [40] suggesting the precursor lesion of ovarian tumors arising in BRCA1 mutation carriers may reside in the fallopian tube rather than the ovarian surface epithelium. These studies have nominated regions of distal fallopian tube mucosa exhibiting stabilized p53 protein, termed "p53 signatures", and occult non-invasive intraepithelial serous carcinomas identified in prophylactic salpingo-oophorectomy specimens of BRCA1 mutation carriers as candidate precursors of invasive ovarian and/or pelvic serous carcinomas. In fact, some suggest "p53 signatures" present in distal fallopian tube of non-BRCA1 carriers as a plausible site of tumor origin for many sporadic ovarian and peritoneal cancers [41]. This may suggest that in attempting to model inherited EOC, the relevant target tissue for recombination and excision of Brca1 and p53 may not be the OSE, but rather the epithelium of the distal fallopian tube. Based on the anatomy of murine distal fallopian tube and ovary, intrabursal injection of Ad5-CMV-Cre would be predicted to result in viral contact with at least a portion of the tubal fimbria. This prediction is supported by our observation of isolated beta-galactosidase positive cells present in the fallopian tube after intrabursal injection of Ad5-CMV-LacZ. However, this strategy appears to result in less frequent recombination in the fallopian tube than the OSE. Interestingly, in a very recent study that used a genetic approach for reproductive tract restricted Cre-recombinase expression by crossing Amhr2-Cre transgenic mice with Brca1LoxP/LoxP and/or p53LoxP/LoxP mice showed that while Cre-mediated recombination of floxed Brca1 and p53 alleles could be demonstrated in the ovaries, fallopian tubes and uteri of compound transgenic mice, the tumors that developed in these mice were all uterine leiomyosarcomas rather than ovarian tumors of any type [42]. Further studies will likely elucidate whether secretory epithelial cells of the tubal fimbria are the primary cell of origin of BRCA1-associated and/or sporadic serous ovarian carcinomas. If this is the case, an alternate strategy for development of mouse models of inherited Brca1-associated, and possibly sporadic serous EOC, would be to develop a transgenic strain of mice that express the Cre-recombinase gene under transcriptional control of a gene expressed selectively in the fallopian tube epithelium, such as the oviduct-specific glycoprotein 1 gene [43], [44].
###end p 45
###begin p 46
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 333 338 333 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 427 431 427 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Chodankar1">[22]</xref>
###xml 514 519 514 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 579 588 579 588 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 574 588 574 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup></italic>
###xml 716 720 716 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fshr</italic>
###xml 783 788 783 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 871 875 871 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Chodankar1">[22]</xref>
###xml 970 975 970 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 1063 1068 1063 1068 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 1246 1251 1246 1251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 1358 1362 1358 1362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Hu1">[45]</xref>
###xml 1401 1406 1401 1406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 1808 1813 1808 1813 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 1817 1820 1817 1820 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1919 1923 1919 1923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Hill1">[46]</xref>
###xml 1925 1929 1925 1929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Patocs1">[47]</xref>
###xml 1931 1935 1931 1935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Weber1">[48]</xref>
###xml 2167 2170 2167 2170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 2241 2245 2241 2245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Coppe1">[49]</xref>
###xml 2403 2407 2403 2407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Beacham1">[50]</xref>
###xml 550 555 <span type="species:ncbi:10090">mouse</span>
###xml 589 593 <span type="species:ncbi:10090">mice</span>
###xml 597 612 <span type="species:ncbi:10090">transgenic mice</span>
###xml 773 777 <span type="species:ncbi:10090">mice</span>
Unlike other tumor suppressor genes, loss or mutation of BRCA1 confers a selective risk for cancer development in organs such as breast, ovary and prostate. The mechanisms of enhanced tissue-specific risk are unclear, but suggest that production of or responsiveness to hormones may play an important role. Recent work suggests that BRCA1 inactivation contributes to ovarian tumor development by cell non-autonomous mechanisms [22]. In this study, investigators used a Cre/LoxP strategy to specifically inactivate Brca1 in the granulosa cells of the mouse ovary by crossing Brca1LoxP/LoxP mice to transgenic mice expressing Cre-recombinase under transcriptional control of the follicle stimulating hormone receptor (Fshr) gene promoter. Otherwise genetically normal female mice with Brca1 inactivated only in granulosa cells developed benign epithelial ovarian neoplasms [22]. Analysis of microdissected epithelial lesions confirmed that no excision of the LoxP-flanked Brca1 allele occurred in these cells, suggesting that restricted conditional inactivation of Brca1 in granulosa cells is sufficient to induce neoplastic alterations in the epithelial compartment in a cell non-autonomous manner. Recent evidence suggests an additional role for BRCA1 in the regulation of aromatase P450 (CYP19), the enzyme that catalyzes conversion of androgen to estrogen [45]. Results from this study suggest that BRCA1 mutation and loss of heterozygosity may predispose cancer formation in steroidogenic tissues by virtue of loss of DNA damage repair mechanisms in the epithelial cell compartments coupled with growth stimulatory paracrine effects on these cells mediated by enhanced estrogen production in local tissues (i.e., granulosa cells and/or preadipocytes). Other studies suggest that selective inactivation of BRCA1 or p53 in the stroma surrounding tumors plays a direct role in tumor progression in steroidogenic organs [46], [47], [48]. Interestingly, recent work showed that cells exhibiting a senescence associated secretory phenotype (SASP) contribute to epithelial to mesenchymal transitions and invasiveness in a cell non-autonomous manner, with inactivation of p53 being a major contributor to these pro-malignant paracrine activities [49]. It is well-established that genetic and/or epigenetic alterations within the underlying tumor stroma have a direct effect on tumor progression (reviewed in [50]). Hence, it is clear that stromal-epithelial interactions are critical to both normal ovarian tissue function and to epithelial tumor initiation and progression in this hormone responsive organ.
###end p 46
###begin p 47
###xml 95 100 95 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 105 108 105 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
Taken together, previously published studies and our own data suggest that loss of function of BRCA1 and p53 cooperate in their contribution to ovarian tumorigenesis, but that additional molecular or epigenetic alterations within tumor cells and/or stroma as well as cell non-autonomous factors contribute to the development of EOC. Further analyses are required to elucidate the mechanisms of BRCA1-mediated transformation of the ovarian epithelium.
###end p 47
###begin title 48
Materials and Methods
###end title 48
###begin title 49
###xml 7 12 <span type="species:ncbi:10090">Mouse</span>
Mutant Mouse Strains
###end title 49
###begin p 50
###xml 183 188 183 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 203 209 203 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm2Brn</sup>
###xml 198 209 198 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>tm2Brn</sup></italic>
###xml 211 215 211 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Liu1">[16]</xref>
###xml 220 223 220 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 238 244 238 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1Brn</sup>
###xml 233 244 233 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trp53<sup>tm1Brn</sup></italic>
###xml 246 250 246 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Jonkers1">[26]</xref>
###xml 463 472 463 472 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 458 472 458 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup></italic>
###xml 480 489 480 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 477 489 477 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>LoxP/LoxP</sup></italic>
###xml 566 569 566 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 574 583 574 583 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">515A/515A</sup>
###xml 571 583 571 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>515A/515A</sup></italic>
###xml 585 589 585 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Lang1">[27]</xref>
###xml 623 626 623 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 666 670 666 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Dittmer1">[28]</xref>
###xml 672 676 672 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Hollstein1">[29]</xref>
###xml 678 682 678 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Olivier1">[30]</xref>
###xml 850 855 850 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 859 862 859 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 873 876 873 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 883 892 883 892 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 878 892 878 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup></italic>
###xml 897 906 897 906 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 894 906 894 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>LoxP/LoxP</sup></italic>
###xml 917 926 917 926 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">515A/515A</sup>
###xml 914 926 914 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>515A/515A</sup></italic>
###xml 1011 1020 1011 1020 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 1024 1033 1024 1033 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 1006 1033 1006 1033 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup>;p53<sup>LoxP/LoxP</sup></italic>
###xml 1040 1049 1040 1049 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 1053 1059 1053 1059 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/515A</sup>
###xml 1035 1059 1035 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup>;p53<sup>+/515A</sup></italic>
###xml 1069 1078 1069 1078 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 1082 1091 1082 1091 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/515A</sup>
###xml 1064 1091 1064 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup>;p53<sup>LoxP/515A</sup></italic>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
###xml 142 146 <span type="species:ncbi:10090">Mice</span>
###xml 274 279 <span type="species:ncbi:10090">Mouse</span>
###xml 290 295 <span type="species:ncbi:9606">Human</span>
###xml 322 327 <span type="species:ncbi:10090">Mouse</span>
###xml 492 496 <span type="species:ncbi:10090">Mice</span>
###xml 659 665 <span type="species:ncbi:9606">humans</span>
###xml 797 801 <span type="species:ncbi:10090">Mice</span>
All procedures in this study involving mice were approved by the Fox Chase Cancer Center Institutional Animal Care and Use Committee (IACUC). Mice harboring LoxP flanked sequences in Brca1 (FVB;129-Brca1tm2Brn) [16] and p53 (FVB;129-Trp53tm1Brn) [26] were obtained from the Mouse Models of Human Cancer Consortium (MMHCC) Mouse Repository (, National Cancer Institute, Frederick, MD) and maintained as homozygous colonies expressing the conditional alleles (Brca1LoxP/LoxP and p53LoxP/LoxP). Mice harboring an arginine to histidine substitution at amino acid 172 of p53 (p53515A/515A) [27], a mutation corresponding to the p53 hot spot mutation at Arg 175 in humans [28], [29], [30], were generously provided by Dr. Guillermina Lozano, University of Texas MD Anderson Cancer Center, Houston, TX). Mice harboring conditional (LoxP flanked) alleles of Brca1 or p53 or mutant p53 (Brca1LoxP/LoxP, p53LoxP/LoxP and/or p53515A/515A) were intercrossed to generate colonies with the following compound genotypes: Brca1LoxP/LoxP;p53LoxP/LoxP, Brca1LoxP/LoxP;p53+/515A and Brca1LoxP/LoxP;p53LoxP/515A.
###end p 50
###begin title 51
Preparation of Genomic DNA and Genotyping Analysis
###end title 51
###begin p 52
###xml 189 193 183 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Connolly1">[17]</xref>
###xml 219 228 213 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 214 228 208 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup></italic>
###xml 264 268 258 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Liu1">[16]</xref>
###xml 270 274 264 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-ClarkKnowles1">[23]</xref>
###xml 309 314 303 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 324 353 318 347 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TATCACCACTGAATCTCTACCG -3&#8242;</named-content>
###xml 358 363 352 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 373 401 367 395 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GACCTCAAACTCTGAGATCCAC-3&#8242;</named-content>
###xml 411 416 405 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 427 455 421 449 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TATTCTTACTTCGTGGCACATC-3&#8242;</named-content>
###xml 460 465 454 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 476 504 470 498 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCCATAGCATCTCCTTCTAAAC-3&#8242;</named-content>
###xml 556 561 550 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 680 689 674 683 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 677 689 671 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>LoxP/LoxP</sup></italic>
###xml 736 740 730 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Jonkers1">[26]</xref>
###xml 775 778 769 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 788 815 782 809 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CACAAAAACAGGTTAAACCAG-3&#8242;</named-content>
###xml 820 823 814 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 833 859 827 853 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGCACATAGGAGGCAGAGAC-3&#8242;</named-content>
###xml 869 872 863 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 883 909 877 903 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AAGGGGTATGAGGGACAAGG-3&#8242;</named-content>
###xml 914 917 908 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 928 954 922 948 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GAAGACAGAAAAGGGGAGGG-3&#8242;</named-content>
###xml 1006 1009 1000 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1131 1135 1125 1129 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">515A</sup>
###xml 1128 1135 1122 1129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>515A</sup></italic>
###xml 1185 1189 1179 1183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Liu2">[51]</xref>
###xml 1233 1234 1227 1228 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8242;</sc>
###xml 1208 1234 1202 1228 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ACCTGTAGCTCCAGCACTGG-3<sc>&#8242;</sc></named-content>
###xml 1241 1242 1235 1236 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8242;</sc>
###xml 1266 1267 1260 1261 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8242;</sc>
###xml 1240 1267 1234 1261 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5<sc>&#8242;</sc>-ACAAGCCGAGTAACGATCAGG-3<sc>&#8242;</sc></named-content>
###xml 1303 1304 1297 1298 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8242;</sc>
###xml 1277 1304 1271 1298 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCATTTGTCACGTCCTGCACG-3<sc>&#8242;</sc></named-content>
###xml 195 199 <span type="species:ncbi:10090">Mice</span>
###xml 658 662 <span type="species:ncbi:10090">Mice</span>
###xml 1106 1110 <span type="species:ncbi:10090">Mice</span>
Genomic DNA was isolated from tail biopsies by overnight digestion in sodium chloride (NaCl)/Tris EDTA/proteinase K solution at 55degreesC and ethanol precipitation as previously described [17]. Mice harboring the Brca1LoxP/LoxP allele were genotyped as described [16], [23] using primers flanking introns 4 (Brca1-int4-Fwd-5'-TATCACCACTGAATCTCTACCG -3' and Brca1-int4-Rev-5'-GACCTCAAACTCTGAGATCCAC-3') and 13 (Brca1-int13-Fwd-5'-TATTCTTACTTCGTGGCACATC-3' and Brca1-int13-Rev-5'-TCCATAGCATCTCCTTCTAAAC-3'). The expected sizes of wild type and LoxP flanked Brca1 sequences were 390 nt and 545 nt for intron 4 and 494 nt and 620 nt for intron 13 respectively. Mice harboring the p53LoxP/LoxP allele were genotyped as previously described [26] using primers flanking introns 1 (p53-int1-Fwd-5'-CACAAAAACAGGTTAAACCAG-3' and p53-int1-Rev-5'-AGCACATAGGAGGCAGAGAC-3') and 10 (p53-int10-Fwd-5'-AAGGGGTATGAGGGACAAGG-3' and p53-int10-Rev-5'-GAAGACAGAAAAGGGGAGGG-3'). The expected sizes of wild type and LoxP flanked p53 sequences were 288 nt and 370 nt for intron 1 and 431 nt and 584 nt for intron 10 respectively. Mice harboring mutant p53515A allele(s) were genotyped as previously described [51] using primers PL5-5'-ACCTGTAGCTCCAGCACTGG-3', PL6-5'-ACAAGCCGAGTAACGATCAGG-3' and NeoR-5'-CCATTTGTCACGTCCTGCACG-3'.
###end p 52
###begin p 53
###xml 371 375 371 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Connolly2">[52]</xref>
###xml 377 381 377 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Tashiro1">[53]</xref>
###xml 530 534 530 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Connolly2">[52]</xref>
###xml 536 540 536 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Tashiro1">[53]</xref>
###xml 641 650 641 650 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 636 650 636 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup></italic>
###xml 655 664 655 664 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 652 664 652 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>LoxP/LoxP</sup></italic>
###xml 742 751 742 751 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 737 751 737 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup></italic>
###xml 797 806 797 802 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 792 806 792 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>&#916;5-13</sup></italic>
###xml 870 875 866 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 889 894 885 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 943 952 939 944 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 938 952 934 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>&#916;5-13</sup></italic>
###xml 1050 1059 1042 1051 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 1047 1059 1039 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>LoxP/LoxP</sup></italic>
###xml 1105 1114 1097 1102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 1102 1114 1094 1102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>&#916;2-10</sup></italic>
###xml 1206 1209 1194 1197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1223 1226 1211 1214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 752 756 <span type="species:ncbi:10090">mice</span>
###xml 1060 1064 <span type="species:ncbi:10090">mice</span>
Genomic DNA was isolated from bulk tumor tissue using the same method as described above. Alternatively, microscopic tumors were manually microdissected. Briefly, adjacent H&E stained sections were aligned with unstained paraffin embedded tissue sections to identify the area containing the tumor lesion which was then scraped with needles or scalpel blades as described [52], [53]. The microdissected tissue was then deparaffinized in xylenes and genomic DNA isolated by standard methods for phenol/chloroform/ethanol extraction [52], [53]. Purified genomic DNA was used for PCR amplification and detection of LoxP-flanked and excised Brca1LoxP/LoxP, p53LoxP/LoxP alleles. Cre recombinase-mediated excision of LoxP flanked sequences in Brca1LoxP/LoxP mice results in deletion of exons 5-13 (Brca1Delta5-13) and was detected by PCR amplification of genomic DNA with the Brca1-int4-Fwd and Brca1-int13-Rev primers. Detection of the 594 nt Brca1Delta5-13 PCR product confirmed excision. Similarly, Cre-mediated excision of LoxP flanked sequences in p53LoxP/LoxP mice resulting in deletion of exons 2-10 (p53Delta2-10) was detected by amplification of a 612 nt PCR product from genomic DNA amplified with the p53-int1-Fwd and p53-int10-Rev primers.
###end p 53
###begin title 54
Adenovirus Administration
###end title 54
###begin p 55
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LacZ</italic>
###xml 422 426 422 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Dinulescu1">[18]</xref>
###xml 428 432 428 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-FleskenNikitin1">[19]</xref>
###xml 434 438 434 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Wu1">[21]</xref>
###xml 440 444 440 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-ClarkKnowles1">[23]</xref>
###xml 446 450 446 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Connolly3">[54]</xref>
###xml 1100 1101 1092 1093 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 68 71 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 104 107 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 387 390 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 485 489 <span type="species:ncbi:10090">mice</span>
###xml 629 634 <span type="species:ncbi:9606">human</span>
###xml 734 738 <span type="species:ncbi:10090">mice</span>
###xml 1139 1142 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Replication defective recombinant adenoviruses expressing LacZ (Ad5-CMV-ntLacZ) or Cre-recombinase (Ad5-CMV-Cre) were purchased from the Gene Transfer Vector Core, University of Iowa, Iowa City, IA. To demonstrate our capability to successfully perform intrabursal injections, we performed pilot experiments in which 8 week-old female C57Bl/6 mice received intrabursal injections of Ad5-CMV-ntLacZ as previously described [18], [19], [21], [23], [54]. To synchronize ovulation, female mice were injected intraperitoneally (i.p.) with 5 U of pregnant mare serum gonadotropin, followed 48 hours later by i.p. injection with 5 U of human chorionic gonadotropin (hormones purchased from Sigma, St. Louis, MO). In preparation for surgery, mice were anesthetized by intraperitoneal injection of 95 microL per 10 gram body weight of 10 mg/mL Ketamine hydrochloride solution and 1 mg/mL Xylazine hydrochloride 36 hours following the last hormone injection. The ovaries were accessed and exposed through a dorsal incision and each ovary received a single intrabursal injection of approximately 10 microL (5x107 plaque forming units, p.f.u.) of Ad5-CMV-ntLacZ virus by inserting a 32G needle coupled with a Hamilton syringe through the oviduct near the infundibulum into the ovarian bursa.
###end p 55
###begin p 56
###xml 47 56 47 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 42 56 42 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>LoxP/LoxP</sup></italic>
###xml 67 76 67 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 64 76 64 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>LoxP/LoxP</sup></italic>
###xml 155 156 155 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 604 605 604 605 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
###xml 130 133 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 192 195 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 204 208 <span type="species:ncbi:10090">Mice</span>
###xml 280 283 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 412 416 <span type="species:ncbi:10090">mice</span>
###xml 534 538 <span type="species:ncbi:10090">mice</span>
###xml 578 582 <span type="species:ncbi:10090">Mice</span>
###xml 703 707 <span type="species:ncbi:10090">mice</span>
For Cre-mediated excision of LoxP-flanked Brca1LoxP/LoxP and/or p53LoxP/LoxP alleles, mice received intrabursal injections of Ad5-CMV-Cre-recombinase (5x107 p.f.u.) as described above for Ad5-CMV-ntLacZ. Mice were subjected to bilateral or unilateral intrabursal injection of Ad5-CMV-Cre or unilateral injection of PBS (controls) and monitored daily for wellness for the first ten days post-surgery. Thereafter, mice were monitored at least twice a week for wellness and the development of palpable tumors. Once tumors were detected, mice were monitored daily until euthanasia. Mice were euthanized by CO2 asphyxiation if estimated tumor palpable tumor volume reached 10% of the total body weight or if mice exhibited any signs of loss-of-wellness, as per IACUC guidelines.
###end p 56
###begin title 57
###xml 17 20 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 46 49 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Detection of Ad5-CMV-ntLacZ Infection and Ad5-CMV-Cre-Mediated Excision
###end title 57
###begin p 58
###xml 168 169 168 169 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 398 399 394 395 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 405 406 401 402 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 414 415 410 411 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 421 422 417 418 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 433 434 429 430 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 23 26 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Mice infected with Ad5-CMV-ntLacZ were euthanized 7 days after intrabursal injection. Ovaries were removed, embedded in OCT medium (Tissue-Tek), snap frozen in liquid N2 and 10 microm sections cut with a cryostat. Sections were fixed for 10 minutes in 0.5% glutaraldehyde, followed by two rinses with PBS+0.1% Tween-20, then stained with X-gal solution (1 mg/mL X-gal (Promega, Madison, WI), 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6, 1 mM MgCl2 in phosphate-buffered saline (PBS)) at 37degreesC overnight in a humidified chamber. Sections were rinsed twice in PBS+0.1% Tween-20, counterstained with Nuclear Fast Red, dehydrated with alcohols, cleared in xylenes, and coverslipped using Permount (Fisher).
###end p 58
###begin p 59
###xml 355 359 349 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Connolly1">[17]</xref>
###xml 968 973 956 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 22 25 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
###xml 232 235 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Tissue restricted Ad5-CMV-Cre infection and Cre-mediated excision of LoxP flanked alleles was confirmed by isolation of genomic DNA from ovary, uterus and liver tissue excised from mice seven days after intrabursal injection of Ad5-CMV-Cre. Tissues were digested in NaCl/Tris EDTA/proteinase K solution at 55degreesC and genomic DNA isolated as described [17]. A tissue lysate enriched for digested OSE was prepared by limiting the initial digestion time of ovary specimens at 55degreesC to 30 min. After the first 30 min., the samples were centrifuged briefly at low speed (1000 rpm) to pellet the undigested ovary. The supernatant was collected and genomic DNA was immediately isolated. To continue digestion of the remainder of the ovary, a fresh aliquot of NaCl/Tris-EDTA/proteinase K digestion buffer was added and the sample digested overnight along with other tissue specimens. Genomic DNA was isolated the following day and subjected to PCR amplification with Brca1 intron 4 and intron 13 primers for detection of LoxP flanked and excised sequences as described above.
###end p 59
###begin title 60
Preparation and Analysis of Tissues, Histology and Immunohistochemistry
###end title 60
###begin p 61
###xml 30 31 30 31 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 525 526 525 526 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 4 8 <span type="species:ncbi:10090">mice</span>
###xml 428 432 <span type="species:ncbi:10090">mice</span>
###xml 804 809 <span type="species:ncbi:9606">human</span>
###xml 814 820 <span type="species:ncbi:10090">murine</span>
All mice were euthanized by CO2 asphyxiation, necropsied and examined for gross abnormalities. Pathologically altered organs, entire reproductive tracts and representative specimens of multiple organs and tissues, including the brain, lung, liver, kidney, spleen, pancreas and intestine were removed at necropsy, fixed in 10% (v/v) neutral buffered formalin (NBF) overnight, transferred to 70% ethanol and paraffin-embedded. In mice with evident tumor, specimens of the tumor tissue were also excised, snap frozen in liquid N2 and stored at -80degreesC. For histological analysis, 5 microm formalin fixed paraffin embedded tissue sections were cut for either H&E staining or immunohistochemistry (IHC). Histopathological analysis was performed by a Board Certified Surgical Pathologist with expertise in human and murine gynecological malignancies (LHE).
###end p 61
###begin p 62
###xml 649 653 637 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008404-Connolly1">[17]</xref>
Sections of tumor tissue for immunohistochemical (IHC) staining were cut on SuperFrost Plus charged slides (Fisher). Antigens (dilution and source of primary antibodies indicated in parenthesis) detected by IHC included: Proliferating nuclear antigen (PCNA, 1:1000; Biogenex), p53 (1:400; Vector Labs), cytokeratin 8 and 19 (CK8, 1:100 and CK19, 1:50; Developmental Studies Hybridoma Bank, The University of Iowa), CD3 (1:100; DAKO), CD45R/B220 (1:200; Pharmingen), alpha-smooth muscle actin (alpha-SMA, 1:100; Sigma) and alpha-inhibin (1:50; Serotec). Unstained sections were deparaffinized, subjected to antigen retrieval and stained as described [17].
###end p 62
###begin title 63
Establishment of Ovarian Cancer Cell Lines and Cell Culture
###end title 63
###begin p 64
###xml 66 67 66 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 148 149 148 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 517 518 513 514 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 566 567 556 557 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
To establish a cell line from an ovarian tumor, approximately 1 cm3 fragments of tumor were excised under aseptic conditions, transferred to a 10 cm2 cell culture dish and finely minced using sterile scalpel blades. Minced tumor tissue was further disaggregated by passing several times through a syringe coupled with a 21(1/2) G needle. The suspension of minced tumor tissue was plated directly in DMEM supplemented with 4% FBS, 1X insulin/transferring/selenium (ITS), penicillin/streptomycin (100 units/mL and 2 mM l-glutamine, and incubated at 37degreesC in 5% CO2. The culture medium was changed twice weekly until the cells reach confluence at which time they were trypsinized and passaged at 4-5 day intervals.
###end p 64
###begin title 65
Array CGH and Karyotype Analysis
###end title 65
###begin p 66
###xml 161 164 157 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alu</italic>
###xml 170 173 166 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rsa</italic>
###xml 803 808 <span type="species:ncbi:10090">mouse</span>
###xml 944 949 <span type="species:ncbi:10090">Mouse</span>
For aCGH, high quality genomic DNA (0.5 to 3 microg) was isolated from frozen tumor specimens using standard methods and digested with restriction endonucleases AluI and RsaI according to the Agilent Oligonucleotide Array-based CGH for Genomic DNA Analysis Version 4.0 protocol. The digested genomic DNA was labeled using Agilent Genomic DNA Labeling Kit PLUS. Test and reference DNA samples were labeled with either cyanine 5- or cyanine 3-dUTP, according to the manufacturer's instructions. Cyanine 5- and cyanine 3-labeled DNA products were then purified using Microcon YM-30 (Millipore) filtration devices. The DNA yield and level of dye incorporation were measured using the ND-1000 Spectrophotometer. Appropriate cyanine 5- and cyanine 3-labeled DNA sample pairs were combined and then mixed with mouse Cot-1 DNA, Agilent 10X Blocking Agent, and Agilent 2X Hybridization Buffer. The labeled target solution was hybridized to Agilent 244K Mouse Genome CGH microarray (G4415A) using SureHyb chambers. After hybridization the microarrays were washed and dried according to the procedures described in the manufacturer's protocol. Microarray slides were scanned immediately using an Agilent microarray scanner. Data for individual features on the microarray were extracted from the scan image using Agilent Feature Extraction (FE) Software. Output files from FE were imported into Agilent CGH data analysis software, CGH Analytics for DNA copy number analysis.
###end p 66
###begin p 67
###xml 42 51 42 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 37 51 37 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>&#916;5-13</sup></italic>
###xml 55 64 51 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 52 64 48 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>&#916;2-10</sup></italic>
A tumor cell line established from a Brca1Delta5-13;p53Delta2-10 ovarian leiomyosarcoma was subjected to karyotype analysis. Preparation of metaphase spreads and trypsin-Giemsa (G) banding were performed according to standard procedures. Chromosome identification and karyotypes designations were in accordance with the University of Washington guidelines ().
###end p 67
###begin title 68
Statistical Analysis
###end title 68
###begin p 69
The Kaplan-Meier method was used to construct survival plots for each data set. Comparisons of each of the data sets were made using the Log-Rank test.
###end p 69
###begin p 70
###xml 239 248 239 248 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">515A/515A</sup>
###xml 236 248 236 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>515A/515A</sup></italic>
###xml 249 253 <span type="species:ncbi:10090">mice</span>
We would like to thank Drs. Andrew Godwin and Margie Clapper for critical reading of this manuscript and helpful discussions. We thank Dr. Guillermina Lozano, University of Texas MD Anderson Cancer Center, Houston, TX for providing the p53515A/515A mice and gratefully acknowledge the technical support provided by the Laboratory Animal, Research Histopathology and Genomics Facilities at Fox Chase Cancer Center.
###end p 70
###begin title 71
References
###end title 71
###begin article-title 72
Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management.
###end article-title 72
###begin article-title 73
BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.
###end article-title 73
###begin article-title 74
###xml 94 99 <span type="species:ncbi:9606">women</span>
Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.
###end article-title 74
###begin article-title 75
BRCA1 and BRCA2: 1994 and beyond.
###end article-title 75
###begin article-title 76
Cancer susceptibility and the functions of BRCA1 and BRCA2.
###end article-title 76
###begin article-title 77
###xml 88 93 <span type="species:ncbi:9606">women</span>
Methylation profiles of sporadic ovarian tumors and nonmalignant ovaries from high-risk women.
###end article-title 77
###begin article-title 78
Inactivation of BRCA1 and BRCA2 in ovarian cancer.
###end article-title 78
###begin article-title 79
Frequency of BRCA1 dysfunction in ovarian cancer.
###end article-title 79
###begin article-title 80
Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer.
###end article-title 80
###begin article-title 81
A somatic mutation in the 5'UTR of BRCA1 gene in sporadic breast cancer causes down-modulation of translation efficiency.
###end article-title 81
###begin article-title 82
The p53 mutational spectrum associated with BRCA1 mutant ovarian cancer.
###end article-title 82
###begin article-title 83
Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumours.
###end article-title 83
###begin article-title 84
Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancers.
###end article-title 84
###begin article-title 85
BRCA1-related papillary serous carcinoma of the peritoneum has a unique molecular pathogenesis.
###end article-title 85
###begin article-title 86
###xml 97 101 <span type="species:ncbi:10090">mice</span>
Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice.
###end article-title 86
###begin article-title 87
###xml 33 37 <span type="species:ncbi:10090">mice</span>
###xml 78 83 <span type="species:ncbi:9606">human</span>
Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer.
###end article-title 87
###begin article-title 88
###xml 7 11 <span type="species:ncbi:10090">mice</span>
###xml 43 58 <span type="species:ncbi:10633">simian virus 40</span>
Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer.
###end article-title 88
###begin article-title 89
###xml 45 50 <span type="species:ncbi:10090">mouse</span>
Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer.
###end article-title 89
###begin article-title 90
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium.
###end article-title 90
###begin article-title 91
###xml 69 74 <span type="species:ncbi:10090">mouse</span>
Induction of ovarian cancer by defined multiple genetic changes in a mouse model system.
###end article-title 91
###begin article-title 92
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 15 20 <span type="species:ncbi:9606">human</span>
Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways.
###end article-title 92
###begin article-title 93
###xml 75 79 <span type="species:ncbi:10090">mice</span>
Cell-nonautonomous induction of ovarian and uterine serous cystadenomas in mice lacking a functional Brca1 in ovarian granulosa cells.
###end article-title 93
###begin article-title 94
###xml 41 46 <span type="species:ncbi:10090">mouse</span>
Conditional inactivation of Brca1 in the mouse ovarian surface epithelium results in an increase in preneoplastic changes.
###end article-title 94
###begin article-title 95
Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation.
###end article-title 95
###begin article-title 96
###xml 2 7 <span type="species:ncbi:10090">mouse</span>
A mouse model for the molecular characterization of brca1-associated ovarian carcinoma.
###end article-title 96
###begin article-title 97
###xml 72 77 <span type="species:ncbi:10090">mouse</span>
Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer.
###end article-title 97
###begin article-title 98
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome.
###end article-title 98
###begin article-title 99
Gain of function mutations in p53.
###end article-title 99
###begin article-title 100
###xml 43 48 <span type="species:ncbi:9606">human</span>
Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation.
###end article-title 100
###begin article-title 101
The IARC TP53 database: new online mutation analysis and recommendations to users.
###end article-title 101
###begin article-title 102
###xml 28 32 <span type="species:ncbi:10090">mice</span>
Inducible gene targeting in mice using the Cre/lox system.
###end article-title 102
###begin article-title 103
###xml 66 70 <span type="species:ncbi:10090">mice</span>
Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice.
###end article-title 103
###begin article-title 104
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Tumor spectrum analysis in p53-mutant mice.
###end article-title 104
###begin article-title 105
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.
###end article-title 105
###begin article-title 106
###xml 35 40 <span type="species:ncbi:10090">mouse</span>
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome.
###end article-title 106
###begin article-title 107
Primary ovarian sarcoma: analysis of prognostic variables and the role of surgical cytoreduction.
###end article-title 107
###begin article-title 108
###xml 117 122 <span type="species:ncbi:9606">women</span>
A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations.
###end article-title 108
###begin article-title 109
A candidate precursor to serous carcinoma that originates in the distal fallopian tube.
###end article-title 109
###begin article-title 110
###xml 66 71 <span type="species:ncbi:9606">women</span>
The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.
###end article-title 110
###begin article-title 111
Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers.
###end article-title 111
###begin article-title 112
Intercepting early pelvic serous carcinoma by routine pathological examination of the fimbria.
###end article-title 112
###begin article-title 113
A role for BRCA1 in uterine leiomyosarcoma.
###end article-title 113
###begin article-title 114
###xml 100 105 <span type="species:ncbi:9606">human</span>
Complementary deoxyribonucleic acid cloning and molecular characterization of an estrogen-dependent human oviductal glycoprotein.
###end article-title 114
###begin article-title 115
Oviductal glycoprotein, a new differentiation-based indicator present in early ovarian epithelial neoplasia and cortical inclusion cysts.
###end article-title 115
###begin article-title 116
Modulation of aromatase expression by BRCA1: a possible link to tissue-specific tumor suppression.
###end article-title 116
###begin article-title 117
Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis.
###end article-title 117
###begin article-title 118
Breast-cancer stromal cells with TP53 mutations and nodal metastases.
###end article-title 118
###begin article-title 119
Total-genome analysis of BRCA1/2-related invasive carcinomas of the breast identifies tumor stroma as potential landscaper for neoplastic initiation.
###end article-title 119
###begin article-title 120
Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor.
###end article-title 120
###begin article-title 121
Stromagenesis: the changing face of fibroblastic microenvironments during tumor progression.
###end article-title 121
###begin article-title 122
###xml 112 116 <span type="species:ncbi:10090">mice</span>
Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice.
###end article-title 122
###begin article-title 123
Somatic mutations in the STK11/LKB1 gene are uncommon in rare gynecological tumor types associated with Peutz-Jegher's syndrome.
###end article-title 123
###begin article-title 124
p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis.
###end article-title 124
###begin article-title 125
###xml 25 30 <span type="species:ncbi:10090">Mouse</span>
Xenograft and Transgenic Mouse Models of Epithelial Ovarian Cancer and Non-Invasive Imaging Modalities to Monitor Ovarian Tumor Growth In Situ: Applications in Evaluating Novel Therapeutic Agents.
###end article-title 125
###begin p 126
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 126
###begin p 127
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by the United States Army Medical Research and Materiel Command (USAMRMC) Congressionally Directed Medical Research Programs (CDMRP [], W81XWH-07-1-0303 and W81XWH-04-1-0063 grants to DCC), National Cancer Institute [] grants: Fox Chase Cancer Center Ovarian Cancer SPORE (P50 CA083638), Fox Chase Cancer Center Core Grant (P30 CA006927). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 127

